Koda Yuya, Mori Takehiko, Shimizu Takayuki, Kato Jun, Yamane Akiko, Sadahira Ken, Tsukada Yuiko, Yokoyama Kenji, Hashimoto Norisato, Hattori Yutaka, Okamoto Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan.
Rinsho Ketsueki. 2012 Aug;53(8):760-4.
We herein report two patients (70- and 45-year-old men) with refractory multiple myeloma who developed paralytic ileus shortly after starting bortezomib therapy. Bortezomib (1.3 mg/m(2)) was given on days 1, 4, 8, and 11 with daily oral solution itraconazole or voriconazole. Twelve and 15 days after beginning the therapy, each patient developed paralytic ileus. Interestingly, no other signs of peripheral neuropathy such as fingertip numbness were observed at the onset of ileus. Sporadic cases of paralytic ileus after bortezomib therapy have been reported, most of which developed ileus after several courses of bortezomib therapy. Our cases developed paralytic ileus shortly after initiating bortezomib, strongly suggesting that autonomic neuropathy due to bortezomib was induced by the concomitant use of itraconazole or voriconazole.
我们在此报告两名难治性多发性骨髓瘤患者(分别为70岁和45岁男性),他们在开始硼替佐米治疗后不久出现麻痹性肠梗阻。硼替佐米(1.3mg/m²)于第1、4、8和11天给药,同时每日口服伊曲康唑或伏立康唑溶液。治疗开始后12天和15天,每名患者均出现麻痹性肠梗阻。有趣的是,在肠梗阻发作时未观察到其他周围神经病变迹象,如指尖麻木。已有硼替佐米治疗后散发性麻痹性肠梗阻病例的报告,其中大多数在几个疗程的硼替佐米治疗后出现肠梗阻。我们的病例在开始硼替佐米治疗后不久就出现了麻痹性肠梗阻,强烈提示硼替佐米所致的自主神经病变是由同时使用伊曲康唑或伏立康唑诱发的。